Literature DB >> 30263707

Anti-diabetic effects of mulberry (Morus alba L.) branches and oxyresveratrol in streptozotocin-induced diabetic mice.

Eunyeong Ahn1, Jimin Lee1, Young-Hee Jeon1, Sang-Won Choi1, Eunjung Kim1.   

Abstract

Despite with accumulating evidences on the anti-diabetic effects of mulberry branch (MB), the major active component for the activity has not been known. Oral administration of MB ethanol (EtOH) extracts [0.5 or 1 g/kg body weight (BW)] once a day for 22 days to streptozotocin-induced diabetic ICR mouse significantly reduced fasting blood and plasma glucose level in a dose dependent manner compared to those of the diabetic control. Administration of oxyresveratrol [ORT, 0.6 g/kg BW], a major compound of MB EtOH extracts, to diabetic ICR mouse also significantly reduced fasting plasma glucose level. Further, ORT increased hepatic glucose transporter 2 transcription and glycogen content. Plasma insulin concentration and intestinal disaccharidase activity were not different between diabetic control and ORT groups. This suggests that ORT reduced plasma glucose by stimulating hepatic glucose uptake and glycogen storage. MB EtOH extracts and ORT could be potential adjunct therapies for diabetes management.

Entities:  

Keywords:  Diabetes; Mouse; Mulberry branch; Oxyresveratrol; Streptozotocin

Year:  2017        PMID: 30263707      PMCID: PMC6049727          DOI: 10.1007/s10068-017-0223-y

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  31 in total

1.  Effect of flavonol glycoside in mulberry (Morus alba L.) leaf on glucose metabolism and oxidative stress in liver in diet-induced obese mice.

Authors:  Takuya Katsube; Masayuki Yamasaki; Kuninori Shiwaku; Tomoko Ishijima; Ichiro Matsumoto; Keiko Abe; Yukikazu Yamasaki
Journal:  J Sci Food Agric       Date:  2010-11       Impact factor: 3.638

Review 2.  Type 2 diabetes in children and adolescents.

Authors:  Marc J Weigensberg; Michael I Goran
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

3.  The estimation of glycogen with the anthrone reagent.

Authors:  S SEIFTER; S DAYTON
Journal:  Arch Biochem       Date:  1950-01

Review 4.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

5.  Assay of intestinal disaccharidases.

Authors:  A Dahlqvist
Journal:  Scand J Clin Lab Invest       Date:  1984-04       Impact factor: 1.713

6.  GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.

Authors:  Z Wang; H Gleichmann
Journal:  Diabetes       Date:  1998-01       Impact factor: 9.461

7.  Pharmacological properties of traditional medicines. XXII. Pharmacokinetic study of mulberroside A and its metabolites in rat.

Authors:  F Qiu; K Komatsu; K Saito; K Kawasaki; X Yao; Y Kano
Journal:  Biol Pharm Bull       Date:  1996-11       Impact factor: 2.233

8.  Differential regulation of two glucose transporters in rat liver by fasting and refeeding and by diabetes and insulin treatment.

Authors:  B Thorens; J S Flier; H F Lodish; B B Kahn
Journal:  Diabetes       Date:  1990-06       Impact factor: 9.461

9.  Extra-pancreatic effects of Momordica charantia in rats.

Authors:  J Welihinda; E H Karunanayake
Journal:  J Ethnopharmacol       Date:  1986-09       Impact factor: 4.360

10.  Colonic Microbiota Encroachment Correlates With Dysglycemia in Humans.

Authors:  Benoit Chassaing; Shreya M Raja; James D Lewis; Shanthi Srinivasan; Andrew T Gewirtz
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-04-13
View more
  4 in total

1.  Characteristics of Mulberry Leaf Powder Enriched With γ-Aminobutyric Acid and Its Antioxidant Capacity as a Potential Functional Food Ingredient.

Authors:  Yingchun Jin; Jie Tu; Xinyao Han; Jun Zhuo; Guanhui Liu; Yanhui Han; Hengjun Du; Jun Wang; Hang Xiao
Journal:  Front Nutr       Date:  2022-05-18

2.  Medicinal properties of Morus alba for the control of type 2 diabetes mellitus: a systematic review.

Authors:  Jorge Guillermo Morales Ramos; Ambrocio Teodoro Esteves Pairazamán; María Ema Soledad Mocarro Willis; Samuel Collantes Santisteban; Emma Caldas Herrera
Journal:  F1000Res       Date:  2021-10-08

3.  LC-MS Metabolite Profiling and the Hypoglycemic Activity of Morus alba L. Extracts.

Authors:  Qing Yi-Jun Zhou; Xin Liao; Hao-Ming Kuang; Jia-Yu Li; Shui-Han Zhang
Journal:  Molecules       Date:  2022-08-23       Impact factor: 4.927

Review 4.  The structure-activity relationship review of the main bioactive constituents of Morus genus plants.

Authors:  Jiejing Yan; Jingya Ruan; Peijian Huang; Fan Sun; Dandan Zheng; Yi Zhang; Tao Wang
Journal:  J Nat Med       Date:  2020-01-02       Impact factor: 3.192

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.